Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples